Gaoqi Xu

1 East Banshan Road
Hangzhou, 310022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

NAT10 drives chemoresistance in AML through ac4C-dependent stabilization of PLEKHA4.

NAT10 drives chemoresistance in AML through ac4C-dependent stabilization of PLEKHA4.

Journal: Biochemical pharmacology

Published: May 18, 2026

Acetaldehyde dehydrogenase 1A1 upregulation drives dacomitinib-induced skin toxicity through mitochondrial dysfunction and keratinocyte apoptosis.

Acetaldehyde dehydrogenase 1A1 upregulation drives dacomitinib-induced skin toxicity through mitochondrial dysfunction and keratinocyte apoptosis.

Journal: Cellular signalling

Published: April 01, 2025

Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with Staphylococcus Aureus by pharmacokinetic/pharmacodynamic analysis.

Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with Staphylococcus Aureus by pharmacokinetic/pharmacodynamic analysis.

Journal: Journal of chemotherapy (Florence, Italy)

Published: April 23, 2024

Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer.

Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer.

Journal: European journal of clinical pharmacology

Published: April 02, 2024

Population pharmacokinetic and exposure-toxicity analyses of nab-paclitaxel after pegylated recombinant human granulocyte colony-stimulating factor administration in patients with metastatic breast cancer.

Population pharmacokinetic and exposure-toxicity analyses of nab-paclitaxel after pegylated recombinant human granulocyte colony-stimulating factor administration in patients with metastatic breast cancer.

Journal: Cancer chemotherapy and pharmacology

Published: March 07, 2024

Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography-tandem mass spectrometry.

Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography-tandem mass spectrometry.

Journal: Journal of separation science

Published: December 15, 2023

Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China.

Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China.

Journal: PloS one

Published: June 07, 2023

Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic study.

Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic study.

Journal: PeerJ

Published: May 15, 2023

Population pharmacokinetics and toxicity correlation analysis of free and liposome-encapsulated doxorubicin in Chinese patients with advanced breast cancer.

Population pharmacokinetics and toxicity correlation analysis of free and liposome-encapsulated doxorubicin in Chinese patients with advanced breast cancer.

Journal: Cancer chemotherapy and pharmacology

Published: April 04, 2023

Population Pharmacokinetics of Anlotinib, a Multiple Receptor Tyrosine Kinase Inhibitor, in Chinese Patients With Malignant Tumors.

Population Pharmacokinetics of Anlotinib, a Multiple Receptor Tyrosine Kinase Inhibitor, in Chinese Patients With Malignant Tumors.

Journal: Journal of clinical pharmacology

Published: January 18, 2023

Correlation of gene expression profiles to identify pancreatic cancer cell lines that best model primary human tumors.

Correlation of gene expression profiles to identify pancreatic cancer cell lines that best model primary human tumors.

Journal: Translational cancer research

Published: January 12, 2023

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma.

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma.

Journal: Journal of oncology

Published: July 19, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026